Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.

@article{ThornleyBrown2006DifferingEO,
  title={Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.},
  author={Denyse P. Thornley-Brown and Xuelei Wang and Jackson T Jr Wright and Otelio S. Randall and Edgar R Iii Miller and James Phillip Lash and Jennifer Youngblut Gassman and Gabriel N. Contreras and Lawrence J. Appel and Lawrence Y C Agodoa and Deanna E Cheek},
  journal={Archives of internal medicine},
  year={2006},
  volume={166 7},
  pages={797-805}
}
BACKGROUND The African American Study of Kidney Disease and Hypertension was a multicenter trial of African Americans with hypertensive kidney disease randomized to an angiotensin-converting enzyme inhibitor (ramipril), a beta-blocker (metoprolol succinate), or a calcium channel blocker (amlodipine besylate). We compared the incidence of type 2 diabetes mellitus (DM) and the composite outcome of impaired fasting glucose or DM (IFG/DM) for the African American Study of Kidney Disease and… CONTINUE READING